Medical implant
Disclosed is a self-expanding medical implant for placement within a lumen of a patient. The implant comprises a woven or non-woven structure having a substantially tubular configuration, and is designed to be low-profile such that it is deliverable with a small diameter catheter. The implant has a high recoverability and desired mechanical properties.
1. An implantable medical device, comprising: a self-expanding tubular structure comprising
at least one strand comprising a first biodegradable material; and
a second biodegradable material at least partially conformally coating said strand; wherein said tubular structure comprises a first diameter greater than 2.5 mm, and said tubular structure recovers to at least 90% of said first diameter after being crimped to a diameter that is less than 50% of said first diameter,
wherein said first diameter is a manufactured diameter of said tubular structure.
2. The implantable medical device of claim 1 , wherein said first biodegradable material comprises poly(lactic acid co-glycolic acid).
3. The implantable medical device of claim 2 , wherein said poly(lactic acid co-glycolic acid) comprises at least about 75 weight percent of lactic acid.
4. The implantable medical device of claim 2 , wherein said poly(lactic acid co-glycolic acid) comprises about 85 weight percent of lactic acid.
5. The implantable medical device of claim 2 , wherein said poly(lactic acid co-glycolic acid) comprises up to about 20 weight percent of lactic acid.
6. The implantable medical device of claim 1 , wherein said second biodegradable material is a random copolymer that is crosslinked.
7. The implantable medical device of claim 1 , wherein said second biodegradable material is selected from the group consisting of poly(lactic acid-co-caprolactone), poly(glycolide-co-caprolactone, poly trimethylene carbonate, and poly(lactic acid-co-dioxanone).
8. The implantable medical device of claim 7 , wherein said second biodegradable material is poly(lactic acid-co-caprolactone) comprising about 50 to 70 weight percent lactic acid.
9. The implantable medical device of claim 8 , wherein said poly(lactic acid-co-caprolactone) is crosslinked with hexamethylene diisocyanate.
10. The implantable medical device of claim 1 , further comprising a therapeutic agent within at least one of said first biodegradable material and said second biodegradable material.
11. An implantable medical device, comprising:
a self-expanding tubular structure comprising
at least one strand comprising a first biodegradable polymer; and
a second biodegradable polymer conformally coating said strand, said second polymer being a thermoset copolymer;
wherein said tubular structure:
comprises a first diameter greater than 4.5 mm;
recovers to at least 90% of said first diameter after being crimped to a to a diameter that is less than 50% of said first diameter, and
exerts a force against a blood vessel wall immediately after being implanted in said blood vessel, wherein said force decreases over time,
and wherein said first diameter is a manufactured diameter of said tubular structure.
12. The implantable medical device of claim 11 , wherein said first diameter is at least about 6.0 mm.
13. The implantable medical device of claim 11 , wherein said first diameter is at least about 7.0 mm.
14. An implantable medical device, comprising: a self-expanding tubular structure comprising
at least one strand comprising a first biodegradable material; and
a second biodegradable material at least partially conformally coating said strand; wherein said tubular structure comprises a first diameter greater than 2.5 mm, and said tubular structure recovers to at least 90% of said first diameter after being crimped to a diameter that is less than 70% of said first diameter,
wherein said first diameter is a manufactured diameter of said tubular structure.
15. The implantable medical device of claim 14 , wherein said first diameter is at least about 6.0 mm.
16. An implantable medical device, comprising:
a self-expanding tubular structure comprising
at least one strand comprising a first biodegradable polymer; and
a second biodegradable polymer conformally coating said strand, said second polymer being a thermoset copolymer;
wherein said tubular structure:
comprises a first diameter greater than 4.5 mm;
recovers to at least 90% of said first diameter after being crimped to a to a diameter that is less than 70% of said first diameter, and
exerts a force against a blood vessel wall immediately after being implanted in said blood vessel, wherein said force decreases over time,
and wherein said first diameter is a manufactured diameter of said tubular structure.